Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose randomized open-label two-way crossover bioequivalence study of generic desloratadine vs Aerius in healthy Thai volunteers under fasting
TCTR20191219001Active, not recruiting
- Sponsor
- Medic Pharma
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of desloratadine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by Medic Pharma. Started Dec 2019; status: active, not recruiting.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20191219001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191219001.